|Security||MSRT / MassRoots, Inc. (57630J106)|
|Industry||Computer Programming, Data Processing, And Other Computer Related Services|
|Common Shares Outstanding||154,487,534 shares (as of 2018-03-31)|
Stock Insider Trading (from SEC Form 4)
MassRoots, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
MSRT / MassRoots, Inc. insiders include Osborn Steven Lee II SHELTON NATHAN E, BLUM CHARLES, Seeb Ean, GALEY LANCE, FITCH TERENCE ANTHONY, Quintero Jesus, PULLAR GEORGE R, Farrar Graham, Hunt Daniel Charles, Fortier Hyler, KYTE CECIL BOND, Dietrich Isaac, Kveton Scott C, and Keber Vincent, .
KYTE CECIL BOND
Kveton Scott C
Osborn Steven Lee II
SHELTON NATHAN E
FITCH TERENCE ANTHONY
PULLAR GEORGE R
Hunt Daniel Charles
Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.
|4||Osborn Steven Lee II||S||D||0.26||-20,000||2,762,321||718,203|
|4||Osborn Steven Lee II||S||D||0.251||-17,500||2,782,321||698,363|
|4||Osborn Steven Lee II||S||D||0.25||-144,821||2,799,821||699,955|
|4||Osborn Steven Lee II||S||D||0.251||-45,000||2,944,642||739,105|
|4||Kveton Scott C||S||D||0.26||-20,000||3,888,533||1,011,019|
|4||Kveton Scott C||S||D||0.251||-17,500||3,908,533||981,042|
|4||Kveton Scott C||S||D||0.25||-144,821||3,926,033||981,508|
|4||Kveton Scott C||S||D||0.2526||-45,000||4,070,854||1,028,298|
|4||Kveton Scott C||S||D||0.2526||-5,000||4,115,854||1,039,665|
|4||Kveton Scott C||S||D||0.252||-25,000||4,120,854||1,038,455|
|4||KYTE CECIL BOND||J||D||750,000||750,000|
|4||Seeb Ean Denver Relief Consulting LLC||J||I||-500,000||393,788|
|4||FITCH TERENCE ANTHONY||J||D||-750,000||100,000|
|4||FITCH TERENCE ANTHONY||A||D||750,000||850,000|
|4||Seeb Ean By Denver Reliev Consulting LLC||A||I||500,000||893,788|
|4||PULLAR GEORGE R||A||D||100,000||100,000|
|4||Seeb Ean By Denver Relief Consulting LLC||J||I||113,788||393,788|
|4||Hunt Daniel Charles||S||D||1.0104||-65,000||255,000||257,652|
|4||Hunt Daniel Charles||S||D||0.9957||-35,000||320,000||318,624|
|4||Hunt Daniel Charles||A||D||25,000||355,000|
|4||Hunt Daniel Charles||A||D||100,000||330,000|
|4||Seeb Ean By E-3 Events, LLC||P||I||0.5||30,000||280,000||140,000|
- Open market or private purchase of non-derivative or derivative security
- Open market or private sale of non-derivative or derivative security
- Grant, award, or other acquisition of securities from the company (such as an option)
- Conversion of derivative
- Sale or transfer of securities back to the company
- Payment of exercise price or tax liability using portion of securities received from the company
- Gift of securities by or to the insider
- Equity swaps and similar hedging transactions
- Exercise or conversion of derivative security received from the company (such as an option)
- A transaction voluntarily reported on Form 4
- Other (accompanied by a footnote describing the transaction)
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
Related News Stories
Stockholders are trying to resell 51.4 million shares acquired in private placements. The transaction could make the share price decline.
(Reuters) - The company that owns High Times, a magazine devoted to marijuana culture, announced on Tuesday that it is launching an equity crowdfunding campaign ahead of its application for an initial public offering on Nasdaq later this year. (13-0)
The company's latest charade is focused around its Blockchain Technologies Inc. subsidiary, a business created around the peak of the cryptocurrency bubble.
as of ET